XML 32 R10.htm IDEA: XBRL DOCUMENT
v3.25.4

Fair Value Measurements | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 28, 2025 | Dec. 29, 2024
Fair Value Measurements [Abstract] |  |
Fair Value Measurements | (4) Fair Value Measurements The following table sets forth the Company’s financial assets and liabilities that are measured at fair value, on a recurring basis (in thousands):
|  | As of September 28, 2025 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Financial Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted cash |  | $ | 3,841 |  |  | $ | — |  |  | $ | — |  |  | $ | 3,841 |
Total |  | $ | 3,841 |  |  | $ | — |  |  | $ | — |  |  | $ | 3,841 |
Financial Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2024 Notes derivative liability |  | $ | — |  |  | $ | — |  |  | $ | 21,664 |  |  | $ | 21,664 |
July 2024 Notes derivative liability – related parties |  |  | — |  |  |  | — |  |  |  | 13,940 |  |  |  | 13,940 |
September 2024 derivative liability |  |  | — |  |  |  | — |  |  |  | 53,301 |  |  |  | 53,301 |
September 2024 derivative liability – related parties |  |  | — |  |  |  | — |  |  |  | 5,922 |  |  |  | 5,922 |
July 2025 Note derivative liability– related party |  |  | — |  |  |  | — |  |  |  | 3,468 |  |  |  | 3,468 |
September 2025 Notes derivative liability |  |  | — |  |  |  | — |  |  |  | 16,274 |  |  |  | 16,274 |
Forward purchase agreement liabilities |  |  | — |  |  |  | — |  |  |  | 4,301 |  |  |  | 4,301 |
Public warrants |  |  | — |  |  |  | — |  |  |  | 2,588 |  |  |  | 2,588 |
Private placement warrants |  |  | — |  |  |  | — |  |  |  | 1,880 |  |  |  | 1,880 |
Working capital warrants |  |  | — |  |  |  | — |  |  |  | 215 |  |  |  | 215 |
SAFE Agreement with related party |  |  | — |  |  |  | — |  |  |  | 497 |  |  |  | 497 |
Total |  | $ | — |  |  | $ | — |  |  | $ | 124,050 |  |  | $ | 124,050 |
|  | As of December 29, 2024 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Financial Assets |  |  |  |  |  |  |  |  |  |  |  |
Restricted cash |  | $ | 3,841 |  |  | $ | — |  |  | $ | — |  |  | $ | 3,841 |
Total |  | $ | 3,841 |  |  | $ | — |  |  | $ | — |  |  | $ | 3,841 |
Financial Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2024 Notes derivative liability |  | $ | — |  |  | $ | — |  |  | $ | 13,563 |  |  | $ | 13,563 |
July 2024 Notes derivative liability – related parties |  |  | — |  |  |  | — |  |  |  | 21,127 |  |  |  | 21,127 |
September 2024 Notes derivative liability |  |  | — |  |  |  | — |  |  |  | 55,474 |  |  |  | 55,474 |
September 2024 Notes derivative liability – related parties |  |  | — |  |  |  | — |  |  |  | 6,958 |  |  |  | 6,958 |
Forward purchase agreement liabilities (1) |  |  | — |  |  |  | — |  |  |  | 3,494 |  |  |  | 3,494 |
Public warrants |  |  | — |  |  |  | — |  |  |  | 862 |  |  |  | 862 |
Private placement warrants |  |  | — |  |  |  | — |  |  |  | 627 |  |  |  | 627 |
Working capital warrants |  |  | — |  |  |  | — |  |  |  | 72 |  |  |  | 72 |
SAFE Agreement with related party |  |  | — |  |  |  | — |  |  |  | 384 |  |  |  | 384 |
Total |  | $ | — |  |  | $ | — |  |  | $ | 102,561 |  |  | $ | 102,561 |
(1) | Includes $1.3 million due to related parties as of and December 29, 2024.
Subsequent to issuance, changes in the fair value of the derivative liabilities, liability classified warrants, forward purchase agreements and SAFEs are recorded within Other expense, net in the Company’s unaudited condensed consolidated statements of operations and comprehensive loss. Derivative liabilities The Company issued derivative liabilities in conjunction with the issuance of certain convertible notes in July 2024 September 2024 and July 2025 (as defined in Note 9 – Borrowings and Derivative Liabilities). The Company valued the derivative liabilities as of September 28, 2025, and December 29, 2024 using a binomial lattice model, which includes Level 3 unobservable inputs. The key inputs used were dividend yield, the Company’s common stock price, volatility, and risk-free rate of the derivative liabilities. The July 2024 Notes derivative liability valuation included the following inputs:
|  | As of |
|  | September 28, 2025 |  |  | December 29, 2024 |
Coupon rate |  |  | 12.0 | % |  |  | 12.0 | %
Conversion rate |  |  | 595.24 |  |  |  | 595.24 |
Conversion price |  | $ | 1.68 |  |  | $ | 1.68 |
Common stock price |  | $ | 1.77 |  |  | $ | 1.81 |
Risk-free rate |  |  | 3.7 | % |  |  | 4.43 | %
Volatility |  |  | 73.9 | % |  |  | 62.0 | %
Dividend yield |  |  | 0.0 | % |  |  | 0.0 | %
The September 2024 Notes derivative liability valuation included the following inputs:
|  | As of |
|  | September 28, 2025 |  |  | December 29, 2024 |
Coupon rate |  |  | 7.0 | % |  |  | 7.0 | %
Conversion rate |  |  | 467.84 |  |  |  | 467.84 |
Conversion price |  | $ | 2.14 |  |  | $ | 2.14 |
Common stock price |  | $ | 1.77 |  |  | $ | 1.81 |
Risk-free rate |  |  | 3.7 | % |  |  | 4.43 | %
Volatility |  |  | 77.8 | % |  |  | 66.6 | %
Dividend yield |  |  | 0.0 | % |  |  | 0.0 | %
The July 2025 Note derivative liability valuation included the following inputs:
|  | As of |
|  | September 28, 2025 |
Coupon rate |  |  | 12.0 | %
Conversion rate |  |  | 558.66 |
Conversion price |  | $ | 1.79 |
Common stock price |  | $ | 1.77 |
Risk-free rate |  |  | 3.7 | %
Volatility |  |  | 75.1 | %
Dividend yield |  |  | 0.0 | %
The September 2025 Notes derivative liability valuation included the following inputs:
|  | As of |
|  | September 28, 2025 |
Coupon rate |  |  | 7.0 | %
Conversion rate |  |  | 467.84 |
Conversion price |  | $ | 2.14 |
Common stock price |  | $ | 1.77 |
Risk-free rate |  |  | 3.7 | %
Volatility |  |  | 77.8 | %
Dividend yield |  |  | 0.0 | %
Public warrants The public warrants are measured at fair value on a recurring basis. The public warrants were valued based on the closing price of the publicly traded instrument. Private placement and working capital warrants The private placement and working capital warrants are measured at fair value. The Company valued the private placement and working capital warrants, based on a Black-Scholes Option Pricing Method, which included the following inputs:
|  | As of |
|  | September 28, |  |  | December 29, |
|  | 2025 |  |  | 2024 |
Expected term |  |  | 2.81 years |  |  |  | 3.56 years |
Expected volatility |  |  | 169.0 | % |  |  | 68.1 | %
Risk-free rate |  |  | 3.65 | % |  |  | 4.39 | %
Expected dividend yield |  |  | 0.00 | % |  |  | 0.00 | %
Forward purchase agreement liabilities In the Third Quarter 2025, the Company entered into individual amendments with Meteora Special Opportunity Fund I, LP (“MSOF”), Meteora Capital Partners, LP (“MCP”), and Meteora Select Trading Opportunities Master, LP (“MSTO”) (with MSOF, MCP, and MSTO collectively as “Meteora”), Sandia Investment Management LP (“Sandia”) and Polar (collectively, the “FPA Amendments”) which among other things, extended the valuation date applicable to each of the FPAs. FPAs are measured at fair value on a recurring basis using a Monte Carlo simulation analysis. The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs:
|  | As of |
|  | September 28, |  |  | December 29, |
|  | 2025 |  |  | 2024 |
VWAP |  | $ | 1.86 |  |  | $ | 1.78 |
Simulation period |  |  | 0.80 years |  |  |  | 0.55 years |
Risk-free rate |  |  | 3.73 | % |  |  | 4.28 | %
Volatility |  |  | 84.8 | % |  |  | 117 | %
SAFE agreement with related party The SAFE Agreement was valued based on a conversion probability of 50% based on historical SAFE agreements and a 50% discount rate at the time of conversion as of September 28, 2025, and December 29, 2024. Financial liabilities not measured at fair value on a recurring basis: The July 2024 Notes, the September 2024 Notes, the July 2025 Note, and the September 2025 Notes were fair valued using a binomial lattice model, which includes Level 3, unobservable inputs. The key inputs used are consistent with those used to fair value the derivative liabilities as discussed under Derivative Liabilities above. The following table sets forth the Company’s financial liabilities that were not measured at fair value, on a non-recurring basis (in thousands):
|  | As of September 28, 2025 |
|  |  |  |  | Fair value |
|  | Carrying value |  |  | Estimated fair value |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Financial Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2024 Notes |  | $ | 36,998 |  |  | $ | 34,187 |  |  | $ | — |  |  | $ | — |  |  | $ | 34,187 |  |  | $ | 34,187 |
July 2024 Notes – related parties |  |  | 8,155 |  |  |  | 22,042 |  |  |  | — |  |  |  | — |  |  |  | 22,042 |  |  |  | 22,042 |
September 2024 Notes |  |  | 15,750 |  |  |  | 78,563 |  |  |  | — |  |  |  | — |  |  |  | 78,563 |  |  |  | 78,563 |
September 2024 Notes – related parties |  |  | 1,714 |  |  |  | 8,729 |  |  |  | — |  |  |  | — |  |  |  | 8,729 |  |  |  | 8,729 |
July 2025 Note – related party |  |  | 1,373 |  |  |  | 6,250 |  |  |  | — |  |  |  | — |  |  |  | 6,250 |  |  |  | 6,250 |
September 2025 Notes |  |  | 4,218 |  |  |  | 25,090 |  |  |  | — |  |  |  | — |  |  |  | 25,090 |  |  |  | 25,090 |
Total |  | $ | 68,208 |  |  | $ | 174,861 |  |  | $ | — |  |  | $ | — |  |  | $ | 174,861 |  |  | $ | 174,861 |
|  | As of December 29, 2024 |
|  |  |  |  | Fair value |
|  | Carrying value |  |  | Estimated fair value |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Financial Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2024 Notes |  | $ | 17,965 |  |  | $ | 21,390 |  |  | $ | — |  |  | $ | — |  |  | $ | 21,390 |  |  | $ | 21,390 |
July 2024 Notes - related parties |  |  | 24,632 |  |  |  | 33,323 |  |  |  | — |  |  |  | — |  |  |  | 33,323 |  |  |  | 33,323 |
September 2024 Notes |  |  | 5,636 |  |  |  | 77,245 |  |  |  | — |  |  |  | — |  |  |  | 77,245 |  |  |  | 77,245 |
September 2024 Notes - related parties |  |  | 476 |  |  |  | 8,583 |  |  |  | — |  |  |  | — |  |  |  | 8,583 |  |  |  | 8,583 |
Total |  | $ | 48,709 |  |  | $ | 140,541 |  |  | $ | — |  |  | $ | — |  |  | $ | 140,541 |  |  | $ | 140,541 |
| (5) Fair Value Measurements The following table sets forth the Company’s financial assets and liabilities that were measured at fair value, on a recurring basis (in thousands):
|  | As of December 29, 2024 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Financial Assets |  |  |  |  |  |  |  |  |  |  |  |
Restricted cash |  | $ | 3,841 |  |  | $ | - |  |  | $ | - |  |  | $ | 3,841 |
Total |  | $ | 3,841 |  |  | $ | - |  |  | $ | - |  |  | $ | 3,841 |
Financial Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2024 derivative liability (1) |  | $ | - |  |  | $ | - |  |  | $ | 34,690 |  |  | $ | 34,690 |
September 2024 derivative liability (1) |  |  | - |  |  |  | - |  |  |  | 62,432 |  |  |  | 62,432 |
Forward purchase agreements (2) |  |  | - |  |  |  | - |  |  |  | 3,494 |  |  |  | 3,494 |
Public warrants |  |  | - |  |  |  | - |  |  |  | 862 |  |  |  | 862 |
Private placement warrants |  |  | - |  |  |  | - |  |  |  | 627 |  |  |  | 627 |
Working capital warrants |  |  | - |  |  |  | - |  |  |  | 72 |  |  |  | 72 |
SAFE Agreement with related party |  |  | - |  |  |  | - |  |  |  | 384 |  |  |  | 384 |
Total |  | $ | - |  |  | $ | - |  |  | $ | 102,561 |  |  | $ | 102,561 |
|  | As of December 31, 2023 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Financial Assets |  |  |  |  |  |  |  |  |  |  |  |
Restricted cash |  | $ | 3,823 |  |  | $ | - |  |  | $ | - |  |  | $ | 3,823 |
Total |  | $ | 3,823 |  |  | $ | - |  |  | $ | - |  |  | $ | 3,823 |
Financial Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Carlyle Warrants |  | $ | - |  |  | $ | - |  |  | $ | 9,515 |  |  | $ | 9,515 |
Public warrants |  |  | 167 |  |  |  | - |  |  |  | - |  |  |  | 167 |
Private placement warrants |  |  | - |  |  |  | 122 |  |  |  | - |  |  |  | 122 |
Working capital warrants |  |  | - |  |  |  | 13 |  |  |  | - |  |  |  | 13 |
Replacement warrants |  |  | - |  |  |  | - |  |  |  | 1,310 |  |  |  | 1,310 |
Forward purchase agreements (1) |  |  | - |  |  |  | - |  |  |  | 3,831 |  |  |  | 3,831 |
Total |  | $ | 167 |  |  | $ | 135 |  |  | $ | 14,656 |  |  | $ | 14,958 |
| (1) | A portion of these balances are with related parties. Refer to Note 15 - Borrowings and Derivative Liabilities for details.
| (2) | A portion of these balances are with related parties. Refer to Note 6 - Forward Purchase Agreements for details.
Subsequent to issuance, changes in the fair value of liability classified warrants, forward purchase agreements and SAFEs are recorded within other income (expense), net in the Company’s consolidated statements of operations and comprehensive loss. Derivative liabilities The Company issued derivative liabilities in conjunction with the issuance of certain convertible notes in July 2024 and September 2024 (refer to Note 15 - Borrowings and Derivative Liabilities). The Company valued the derivative liabilities as of their issuance date and as of December 29, 2024 using a binomial lattice model, which includes level 3 unobservable inputs. The key inputs used were dividend yield, the Company’s common stock price, volatility, risk-free rate and the expected term of the derivative liabilities. The derivative liability valuation included the following inputs as of December 29, 2024:
|  | September Notes |  |  | July Notes |
Coupon rate |  |  | 7.0 | % |  |  | 12.0 | %
Conversion rate |  |  | 467.84 |  |  |  | 595.24 |
Conversion price |  | $ | 2.14 |  |  | $ | 1.68 |
Common stock price |  | $ | 1.81 |  |  | $ | 1.81 |
Dividend Yield |  |  | 0.0 | % |  |  | 0.0 | %
Carlyle Warrants As part of the Company’s amended and restated warrant agreement with CRSEF Solis Holdings, LLC and its affiliates (“Carlyle”), the Company issued Carlyle a warrant to purchase shares of Company Common Stock at a price per share of $0.01. Refer to Note 14 - Warrants for further details. In connection with an exchange of debt effective July 1, 2024, as discussed in Note 15 - Borrowings and Derivative Liabilities, the number of shares expected to be issued in connection with the Carlyle Warrant became fixed and the Carlyle Warrant was reclassified from liability to equity. Accordingly, the Carlyle Warrant is not subject to a fair value measurement as of December 29, 2024. The Company valued the Carlyle Warrants as of December 31, 2023, based on a Black-Scholes Option Pricing Method, which included the following inputs:
|  | As of December 31, |
|  | 2023 |
Expected term |  |  | 7.0 years |
Expected volatility |  |  | 77 | %
Risk-free interest rate |  |  | 3.92 | %
Expected dividend yield |  |  | 0.00 | %
Public Warrants The public warrants are measured at fair value on a recurring basis. The public warrants were valued based on the closing price of the publicly traded instrument. Private Placement and Working Capital Warrants The private placement and working capital warrants are measured at fair value. The Company valued the private placement and working capital warrants, based on a Black-Scholes Option Pricing Method, which included the following inputs:
|  | As of December 29, |
|  | 2024 |
Expected term |  |  | 3.56 years |
Expected volatility |  |  | 68.1 | %
Risk-free interest rate |  |  | 4.39 | %
Expected dividend yield |  |  | 0.00 | %
As of December 31, 2023, the private placement and working capital warrants were valued using observable inputs for similar publicly traded instruments. Forward Purchase Agreement Liabilities FPAs are measured at fair value on a recurring basis using a Monte Carlo simulation analysis. The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs:
|  | As of |
|  | December 29, |  |  | December 31, |
|  | 2024 |  |  | 2023 |
VWAP |  | $ | 1.78 |  |  | $ | 1.66 |
Simulation period |  |  | 0.55 years |  |  |  | 1.55 years |
Risk-free rate |  |  | 4.28 | % |  |  | 4.48 | %
Volatility |  |  | 117 | % |  |  | 95 | %
SAFE Agreement The SAFE Agreement was valued based on a conversion probability of 50% based on historical SAFE agreements and a 50% discount rate at the time of conversion as of December 29, 2024. Replacement Warrants There were no replacement warrants as of December 29, 2024. The Company valued the Replacement Warrants as of December 31, 2023, based on a Black-Scholes Option Pricing Method, which included the following inputs:
|  | As of December 31, |
|  | 2023 |
Expected term |  |  | 0.3 years |
Expected volatility |  |  | 78.5 | %
Risk-free interest rate |  |  | 5.4 | %
Expected dividend yield |  |  | 0 | %
The following table sets forth the Company’s financial liabilities that were not measured at fair value, on a non-recurring basis (in thousands):
|  | As of December 29, 2024 |
|  |  |  |  | Fair value |
|  | Carrying value |  |  | Estimated fair value |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Financial Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
12% Notes |  | $ | 17,965 |  |  | $ | 21,390 |  |  | $ | - |  |  | $ | - |  |  | $ | 21,390 |  |  | $ | 21,390 |
12% Notes - related parties |  |  | 24,632 |  |  |  | 33,323 |  |  |  | - |  |  |  | - |  |  |  | 33,323 |  |  |  | 33,323 |
7% Notes |  |  | 5,636 |  |  |  | 77,245 |  |  |  | - |  |  |  | - |  |  |  | 77,245 |  |  |  | 77,245 |
7% Notes - related parties |  |  | 476 |  |  |  | 8,583 |  |  |  | - |  |  |  | - |  |  |  | 8,583 |  |  |  | 8,583 |
Total |  | $ | 48,709 |  |  | $ | 140,541 |  |  | $ | - |  |  | $ | - |  |  | $ | 140,541 |  |  | $ | 140,541 |
As of December 29, 2024, the 12% Notes and the 7% Notes were fair valued using a binomial lattice model, which includes Level 3, unobservable inputs. The key inputs used are consistent with those used to fair value the derivative liabilities as discussed under Derivative liabilities above.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 940 -SubTopic 820 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration